Nautilus Biotechnology Statistics
NASDAQ: NAUTIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
2.12-0.05 (-2.30%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Nautilus Biotechnology by the numbers
Nautilus Biotechnology has a market capitalization of $270.0 million based on 127.37M shares outstanding. With trailing EPS of $-0.46, Nautilus Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.3% above its 50-day average and 0.7% below its 200-day average.
Average daily trading volume is 6.25M shares, or about $13.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NAUT valuation vs. peer median
| Metric | NAUT | Peer median | Difference |
|---|---|---|---|
| Market cap | $270.03M | $57.76M | +368% |
| Avg. volume | 6.25M | 649.32K | +863% |
Peer median across 8 companies: LAB, QTRX, SEER, HBIO, RPID, PACB, PRPO, EYPT.
Valuation
- Market cap
- $270.03M
- EPS (TTM)
- $-0.46
- Shares outstanding
- 127.37M
Price and trading
- Previous close
- 2.17
- Open
- 2.12
- Day range
- 1.91 – 2.17
- 52-week range
- 0.841 – 4.31
- 52-week change
- -5.36%
- Beta
- —
- Volume
- 6.24M
- Average volume
- 6.25M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 27, 2026
Additional statistics
- Market Cap
- 270.03M
- Forward Pe
- -2.86
- Eps
- -0.46
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.31
- Week52 Low
- 0.84
- Avg Volume
- 6.25M
- Shares Outstanding
- 127.37M
- Ma50
- 2.00
- Ma200
- 2.13
- Earnings Date
- Oct 27, 2026
- Pct From52w High
- -50.81%
- Pct From52w Low
- 152.08%